Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p

Background Circular RNAs (circRNAs) have been demonstrated to act as key regulators in the chemoresistance of human cancers, including breast cancer (BC). Here, we aimed to explore the role of circ‐RNF111 in paclitaxel (PTX) resistance of BC. Methods Quantitative real‐time polymerase chain reaction...

Full description

Bibliographic Details
Main Authors: Hongliang Zang, Yuhui Li, Xue Zhang, Guomin Huang
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.13475
_version_ 1818198938989101056
author Hongliang Zang
Yuhui Li
Xue Zhang
Guomin Huang
author_facet Hongliang Zang
Yuhui Li
Xue Zhang
Guomin Huang
author_sort Hongliang Zang
collection DOAJ
description Background Circular RNAs (circRNAs) have been demonstrated to act as key regulators in the chemoresistance of human cancers, including breast cancer (BC). Here, we aimed to explore the role of circ‐RNF111 in paclitaxel (PTX) resistance of BC. Methods Quantitative real‐time polymerase chain reaction (qRT‐PCR) was employed to determine the expression of circ‐RNF111, microRNA‐140‐5p (miR‐140‐5p) and E2F transcription factor 3 (E2F3) mRNA. The half maximal inhibitory concentration (IC50) of PTX, cell viability, colony formation and cell invasion were assessed by cell counting kit‐8 (CCK‐8) assay, colony formation assay and transwell assay, respectively. Glucose consumption and lactate production were determined by specific kits. A murine xenograft model was established to investigate the role of circ‐RNF111 in PTX resistance of BC in vivo. Dual‐luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to verify the relationship between miR‐140‐5p and circ‐RNF111 or E2F3. Western blot assay was conducted to examine the protein level of E2F3. Results Circ‐RNF111 was upregulated in PTX‐resistant BC tissues and cells. Circ‐RNF111 knockdown restrained IC50 of PTX, cell viability, colony numbers, cell invasion and glycolysis in PTX‐resistant BC cells in vitro and enhanced PTX sensitivity in vivo. MiR‐140‐5p was a target of circ‐RNF111 and miR‐140‐5p expression was negatively correlated with circ‐RNF111 expression in BC tissues. The effect of circ‐RNF111 knockdown on PTX resistance was rescued by miR‐140‐5p deletion. Additionally, miR‐140‐5p could interact with E2F3 and negatively regulate E2F3 expression. Moreover, miR‐140‐5p suppressed IC50 of PTX, cell viability, colony numbers, cell invasion and glycolysis by targeting E2F3. Conclusions Circ‐RNF111 improved PTX resistance of BC by upregulating E2F3 via sponging miR‐140‐5p.
first_indexed 2024-12-12T02:13:50Z
format Article
id doaj.art-f804fba2f14041999a46599d99e0fb6a
institution Directory Open Access Journal
issn 1759-7706
1759-7714
language English
last_indexed 2024-12-12T02:13:50Z
publishDate 2020-07-01
publisher Wiley
record_format Article
series Thoracic Cancer
spelling doaj.art-f804fba2f14041999a46599d99e0fb6a2022-12-22T00:41:50ZengWileyThoracic Cancer1759-77061759-77142020-07-011171891190310.1111/1759-7714.13475Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5pHongliang Zang0Yuhui Li1Xue Zhang2Guomin Huang3Department of General Surgery China‐Japan Union Hospital of Jilin University Changchun ChinaDepartment of General Surgery China‐Japan Union Hospital of Jilin University Changchun ChinaDepartment of General Surgery China‐Japan Union Hospital of Jilin University Changchun ChinaDepartment of General Surgery China‐Japan Union Hospital of Jilin University Changchun ChinaBackground Circular RNAs (circRNAs) have been demonstrated to act as key regulators in the chemoresistance of human cancers, including breast cancer (BC). Here, we aimed to explore the role of circ‐RNF111 in paclitaxel (PTX) resistance of BC. Methods Quantitative real‐time polymerase chain reaction (qRT‐PCR) was employed to determine the expression of circ‐RNF111, microRNA‐140‐5p (miR‐140‐5p) and E2F transcription factor 3 (E2F3) mRNA. The half maximal inhibitory concentration (IC50) of PTX, cell viability, colony formation and cell invasion were assessed by cell counting kit‐8 (CCK‐8) assay, colony formation assay and transwell assay, respectively. Glucose consumption and lactate production were determined by specific kits. A murine xenograft model was established to investigate the role of circ‐RNF111 in PTX resistance of BC in vivo. Dual‐luciferase reporter assay and RNA immunoprecipitation (RIP) assay were performed to verify the relationship between miR‐140‐5p and circ‐RNF111 or E2F3. Western blot assay was conducted to examine the protein level of E2F3. Results Circ‐RNF111 was upregulated in PTX‐resistant BC tissues and cells. Circ‐RNF111 knockdown restrained IC50 of PTX, cell viability, colony numbers, cell invasion and glycolysis in PTX‐resistant BC cells in vitro and enhanced PTX sensitivity in vivo. MiR‐140‐5p was a target of circ‐RNF111 and miR‐140‐5p expression was negatively correlated with circ‐RNF111 expression in BC tissues. The effect of circ‐RNF111 knockdown on PTX resistance was rescued by miR‐140‐5p deletion. Additionally, miR‐140‐5p could interact with E2F3 and negatively regulate E2F3 expression. Moreover, miR‐140‐5p suppressed IC50 of PTX, cell viability, colony numbers, cell invasion and glycolysis by targeting E2F3. Conclusions Circ‐RNF111 improved PTX resistance of BC by upregulating E2F3 via sponging miR‐140‐5p.https://doi.org/10.1111/1759-7714.13475Breast cancercirc‐RNF111E2F3miR‐140‐5pPTX
spellingShingle Hongliang Zang
Yuhui Li
Xue Zhang
Guomin Huang
Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
Thoracic Cancer
Breast cancer
circ‐RNF111
E2F3
miR‐140‐5p
PTX
title Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
title_full Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
title_fullStr Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
title_full_unstemmed Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
title_short Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR‐140‐5p
title_sort circ rnf111 contributes to paclitaxel resistance in breast cancer by elevating e2f3 expression via mir 140 5p
topic Breast cancer
circ‐RNF111
E2F3
miR‐140‐5p
PTX
url https://doi.org/10.1111/1759-7714.13475
work_keys_str_mv AT hongliangzang circrnf111contributestopaclitaxelresistanceinbreastcancerbyelevatinge2f3expressionviamir1405p
AT yuhuili circrnf111contributestopaclitaxelresistanceinbreastcancerbyelevatinge2f3expressionviamir1405p
AT xuezhang circrnf111contributestopaclitaxelresistanceinbreastcancerbyelevatinge2f3expressionviamir1405p
AT guominhuang circrnf111contributestopaclitaxelresistanceinbreastcancerbyelevatinge2f3expressionviamir1405p